Exact Sciences CEO Kevin Conroy sells $4.6M in stock — 3 insights

Exact Sciences CEO Kevin Conroy sold 101,488 shares of stock for approximately $4.64 million Feb. 9, Dispatch Tribunal reports.

Advertisement

Here’s what you should know:

1. Mr. Conroy sold the shares at an average price of $45.72.

2. It’s estimated he still owns 931,540 shares of the company, valued at $42.59 million.

3. Currently, market analysts rate Exact as a “buy,” attaching an average price target of $52.82.

More articles on gastroenterology:
2 ASCs & outpatient facilities achieving certification and accreditation — January 2018
The opioid crisis cost $1T+ since 2001, may cost additional $500B by 2020: 6 takeaways
How the right technology platform can support GI practice growth and patient experience

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.